Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13,083 | 20,194 | 15,268 | 13,778 | 13,381 |
| Income taxes - deferred | -3,115 | -8,829 | -1,944 | -2,678 | -3,674 |
| Accounts receivable | -11,762 | -9,108 | 317 | -13,174 | -7,993 |
| Accounts payable and accrued liabilities | 2,678 | 17,397 | -233 | 8,515 | 4,948 |
| Other Working Capital | -14,925 | -493 | -3,604 | -5,770 | -2,219 |
| Other Operating Activity | 17,752 | -14,409 | 1,525 | 10,850 | 8,436 |
| Operating Cash Flow | $3,711 | $4,752 | $11,329 | $11,521 | $12,879 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -124 | -2,246 | -563 | -23 | -53 |
| Purchase Of Investment | -109,238 | -101,526 | -24,259 | -43,840 | -15,848 |
| Sale Of Investment | 108,315 | 45,896 | 21,600 | 46,502 | 36,546 |
| Purchase Sale Intangibles | -7,667 | -4,407 | -74 | -18,216 | -234 |
| Other Investing Activity | 0 | -2,741 | 0 | 0 | 407 |
| Investing Cash Flow | $-8,714 | $-65,024 | $-3,296 | $-15,577 | $20,818 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 647 | 51,361 | 0 | 0 | 422 |
| Debt Repayment | -1,492 | -12,931 | -681 | -6,034 | -646 |
| Common Stock Repurchased | -10,514 | -8,684 | -4,463 | -10,259 | -6,663 |
| Other Financing Activity | 92 | 112 | 65 | 88 | 75 |
| Financing Cash Flow | $-11,267 | $29,858 | $-5,079 | $-16,205 | $-6,812 |
| Exchange Rate Effect | 809 | 271 | 5,749 | -77 | 609 |
| Beginning Cash Position | 71,679 | 101,822 | 93,119 | 113,457 | 85,963 |
| End Cash Position | 56,218 | 71,679 | 101,822 | 93,119 | 113,457 |
| Net Cash Flow | $-16,270 | $-30,414 | $2,954 | $-20,261 | $26,885 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,711 | 4,752 | 11,329 | 11,521 | 12,879 |
| Capital Expenditure | -7,791 | -6,653 | -637 | -18,239 | -287 |
| Free Cash Flow | -4,080 | -1,901 | 10,692 | -6,718 | 12,592 |